NCT06031324 The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory Distress
| NCT ID | NCT06031324 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bursa City Hospital |
| Condition | Respiratory Distress Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-11 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-11 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Respiratory distress in term and late preterm infants in the first hour after birth is a prevalent condition. This situation may occur due to different reasons such as minimal respiratory stress, transient tachypnea of newborn, respiratory distress syndrome, and congenital pneumonia. It can be not easy to distinguish this in the first hours. This study aimed to investigate the place of the lung ultrasonography score in the prognosis of these patients.
Eligibility Criteria
Inclusion Criteria: * Having symptoms of respiratory distress that begin soon after birth, * \> 34 gestational age, * \>1900 gr birth weight, * Family consent Exclusion Criteria: * Congenital anomaly * Chromosomal anomaly * Hydrops fetalis * Congenital heart disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06031324 clinical trial?
This trial is open to participants of all sexes, aged 30 Minutes or older, up to 120 Minutes, studying Respiratory Distress Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06031324 currently recruiting?
Yes, NCT06031324 is actively recruiting participants. Contact the research team at bayramalidorum@gmail.com for enrollment information.
Where is the NCT06031324 trial being conducted?
This trial is being conducted at Bursa, Turkey (Türkiye).
Who is sponsoring the NCT06031324 clinical trial?
NCT06031324 is sponsored by Bursa City Hospital. The trial plans to enroll 100 participants.